Bringing Induced Pluripotent Stem Cell Technology to the Bedside

· by · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. ·


Figure 1. iPSCs describe cells that have been reprogrammed to the pluripotent state. In the illustration, a somatic cell has had OSKM exogenously expressed to initiate the reprogramming mechanism…more
https://www.jmaj.jp/detail.php?id=10.31662%2Fjmaj.2018-0005

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Google photo

You are commenting using your Google account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.